SCHEMBL6002186

SCHEMBL6002186

CN1CCN(c2cccc3c(Cl)cccc23)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.69
DRD3 P35462 5/20 0.69
HTR1A P08908 2/20 0.53
DRD4 P21917 1/20 0.53
HTR2A P28223 1/20 0.53
HTR2C P28335 1/20 0.53
ADRA2C P18825 1/20 0.49
BCL2A1 Q16548 2/20 0.48
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
RAD52 P43351 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2A6 P11509 1/20 0.46
POLB P06746 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
NCF1 P14598 1/20 0.45
HTR3E A5X5Y0 1/20 0.45
HTR3B O95264 1/20 0.45
HTR3A P46098 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002162 0.89 DRD2 (0.54) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL424507 0.83 DRD2 (0.75) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL3399254 0.81 DRD2 (1.00) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL12359055 0.80 DRD2 (0.71) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL1127096 0.79 ADRA2C (0.68) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL5362957 0.79 ADRB1 (0.70) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL6002177 0.78 HTR1A (0.62) DRD2DRD3HTR1AHTR2AADRA2C
SCHEMBL27359418 0.76 HTR1A (0.61) DRD2DRD3HTR1AHTR2AADRA2C
SCHEMBL25106971 0.76 DRD2 (0.65) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL3399574 0.76 DRD2 (0.87) DRD2DRD3HTR1ADRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166984-A1 Amino substituted benzo(hetero)cyclic derivatives BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 US disclosed
EP-1603395-A2 AMINO SUBSTITUTED BENZO(HETERO)CYCLIC DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2005-12-14 EP disclosed
WO-2004080170-A2 AMINO SUBSTITUTED BENZO(HETERO)CYCLIC DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166984-A1 Amino substituted benzo(hetero)cyclic derivatives CBR3, L3MBTL3, BRS3 DRD2 1222/4885DRD3 580/4885HTR1A 2209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.